Corteva (CTVA) Q2 2024 earnings summary

Executive summary

• Q2 2024 net sales rose 1% year-over-year to $6.1B, with operating EBITDA up 10% to $1.92B, driven by strong Seed performance and margin expansion, while Crop Protection faced ongoing pricing and volume pressures.

• Seed business achieved record operating EBITDA in H1 2024, with broad-based pricing gains and leadership in North America corn and soybeans.

• Crop Protection volumes grew 6% in Q2, but segment EBITDA and sales declined in H1 due to competitive pricing and destocking, though industry stabilization is emerging.

• CFO transition announced: David Johnson to succeed Dave Anderson in September 2024, ensuring leadership continuity.

Financial highlights

• Q2 2024 operating EBITDA margin improved to 31.4%, up 248–250 bps year-over-year; Seed segment Q2 margin at 39.2%, up 500 bps; Crop Protection Q2 margin at 14.3%, down 365 bps.

• 1H 2024 net sales were $10.6B, down 3% year-over-year; operating EBITDA was $2.95B, slightly below prior year, but with margin expansion.

• Royalty income grew 40% year-over-year in H1, adding $35M, led by new corn trait technologies.

• Share repurchases on track for $1B in 2024; annual dividend increased by 6–6.25%.

Outlook and guidance

• Full-year 2024 net sales guidance revised to $17.2–$17.5B (up 1% at midpoint); operating EBITDA $3.4–$3.6B (up 4% at midpoint); operating EPS $2.60–$2.80 (flat at midpoint).

• Free cash flow guidance reaffirmed at $1.5–$2.0B, with a midpoint of $1.75B and 45–50% cash flow to EBITDA conversion.

• Dividend increased 6%, with $1B in share repurchases planned for FY 2024.

• 2025 outlook constructive, with focus on royalty benefits, productivity, and cost deflation; more details at Investor Day in November.